Speech-Language Pathologists in Boonville, MO Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Risa L Venable, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Main St, Special Services, Boonville, MO 65233 Phone: 660-882-7474    Fax: 660-882-5721

Jane Brengarth Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Main St, Boonville, MO 65233 Phone: 660-882-7474

Ellison Brunkhorst Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 W Ashley Rd, Boonville, MO 65233 Phone: 660-882-2744

Mrs. Debra S Huff, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Main St, Boonville, MO 65233 Phone: 660-882-7474    Fax: 660-882-5721

Laura Reans, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 814 Locust St, Boonville, MO 65233 Phone: 660-882-6527

Mrs. Kim Jean Stephens, MHS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 W Ashley Rd, Boonville, MO 65233 Phone: 660-882-2744

News Archive

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort, for approximately $254.6 million in cash.

Kansas Bioscience Authority commits to invest $50 million in eight private venture capital funds

The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.

Dr. Pinchas Tsukerman earns prestigious Kaye Innovation Award for research on cancer immunotherapy

The importance of the body's immune system in protecting against the creation of cancerous tumors has been known for a long time. But despite the existence of a competent immune system, some individuals develop tumors, in part because tumors have ways to evade destructive immunity or induce immune-suppression.

Thomson Reuters study tracks current status of research on NTDs

"The Intellectual Property & Science division of Thomson Reuters on Tuesday announced the publication of a new study tracking the current status of research on neglected tropical diseases [NTDs]," a Thomson Reuters Corporation press release reports.

Warwick first new medical school to join MRC strategic partnership

Warwick Medical School has become the first new medical school to join a strategic partnership with the Medical Research Council (MRC).

Read more Medical News

› Verified 5 days ago